Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077415
Status:
COMPLETED
Last Update Posted:
2013-05-15
First Post:
2004-02-10
Brief Title:
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Sponsor:
Cancer Therapeutics Research Group
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2004-02-10
First Submit QC Date:
February 11 2004
Study First Post Date:
2004-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-14
Last Update Post Date:
2013-05-15
Last Update Post Date Type:
ESTIMATED